Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities
M. R. Kelly, K. Kostyrko, K. Han, N. Mooney, E. E. Jeng, K. L. Abbott, D. M. Gwinn, E. A. Sweet-Cordero, M. C. Bassik, P. K. Jackson
The paper identifies new RAS effector pathways and synthetic lethal interactions in lung adenocarcinoma using proteomic and genetic screening.
bioRxiv · Apr 20, 2020Cancer Biology